We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

42 hedge funds and large institutions have $108M invested in T2 Biosystems, Inc in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

2% more funds holding

Funds holding: 4142 (+1)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

3% less call options, than puts

Call options by funds: $155K | Put options by funds: $159K

28% less capital invested

Capital invested by funds: $151M → $108M (-$42.7M)

Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
1.05%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
4
Increased
11
Reduced
7
Closed
3
Calls
$155K
Puts
$159K
Net Calls
-$4K
Net Calls Change
-$50K

TTOO Hedge Fund Activity: Q4 2016 in Review

42 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2016, worth a combined $108M — down 28% from $151M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TTOO positions and 3 closed out — a net gain of 1 holder — while 11 added to existing stakes and 7 trimmed.

The largest buyer was Senvest Management, adding an estimated $1.63M. The largest seller was Point72 Asset Management, cutting an estimated $2.37M.

  • 42 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2016, up from 41 in Q3 2016.
  • Funds reported $108M of T2 Biosystems, Inc stock for Q4 2016, down 28% quarter-over-quarter.
  • 4 funds opened new T2 Biosystems, Inc positions in Q4 2016 and 3 closed out, a net change of +1 holder.
  • The largest T2 Biosystems, Inc buyer in Q4 2016 was Senvest Management, an estimated $1.63M added.
  • The largest T2 Biosystems, Inc seller in Q4 2016 was Point72 Asset Management, an estimated $2.37M sold.

Based on aggregated 13F filings for Q4 2016.